Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
In 1974, Stominger became a member of the Dana–Farber Cancer Institute, a cancer treatment and research institution in Boston, Massachusetts, one of the clinical affiliates and research institutes of Harvard Medical School. [3] At that time, the institute's director was Emil Frei who had been a classmate with Strominger at Yale Medical School.
Marty Smith (November 26, 1956 – April 27, 2020) was an American professional motocross racer. [1] He competed in the AMA Motocross Championships from 1974 to 1981, most prominently as a member of the Honda factory racing team with whom he won 18 AMA race victories and three National Motocross championships. [1]
Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School.D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility.
At Dana-Farber, Glimcher collaborated on research to find methods of combatting cancer from within the human immune system. [18] The Dana–Farber Cancer Institute is an institution that is affiliated with Harvard, as it currently is one of its teaching hospitals. Glimcher, who was the first female dean of any medical school in New York state ...
While at Dana-Farber, he also served as the lead investigator for Dendreon's clinical trials for Sipuleucel-T, a therapeutic vaccine for prostate cancer approved in 2010. [7] After 28 years at Dana-Farber, Kantoff joined Memorial Sloan Kettering Cancer Center in 2015 to replace George J. Bosl as the Chairman of Medicine.
Einar Gustafson (August 18, 1935 – January 21, 2001) [1] gained fame as a 12-year-old cancer patient when he became nationally known as "Jimmy". The name started a fund-raising program in 1948 known as The Jimmy Fund for the Dana–Farber Cancer Institute.
Armstrong and his team also became the first to isolate rare leukemia stem cells in a mouse model of leukemia. [ 7 ] As a result of his genome-wide technologies to characterize the molecular pathways responsible for leukemia development, Armstrong was elected a member of the American Society for Clinical Investigation [ 8 ] and was the ...